Journal
BLOOD
Volume 110, Issue 3, Pages 847-850Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2007-01-067546
Keywords
-
Categories
Funding
- MRC [G0500429] Funding Source: UKRI
- Medical Research Council [G0500429] Funding Source: researchfish
- Medical Research Council [G0500429] Funding Source: Medline
Ask authors/readers for more resources
Foxp3+ regulatory T cells (Tregs) play a central role in maintaining immune tolerance. A reduction in the function of Tregs is a key feature of autoimmune diseases, whereas their expansion in malignant diseases leads to the suppression of host antitumor responses. We analyzed the absolute number of CD4(+) and CD8(+) Tregs in the peripheral blood of 52 patients with myelodysplastic syndrome (IMDS) and show a significant correlation between increased number of CD4(+) Tregs and MDS subgroups with 5% or more bone marrow blasts (P<.001), high International Prognostic Scoring System (IPSS) score (P <.001), and disease progression (P <.001), whereas no correlation between CD8(+) Tregs and prognostic variables was observed. The CD4(+) Tregs showed a polyclonal spectratype, and the percentage of the naive subset was significantly higher in the high-risk patients compared with low-risk or healthy agematched donors (P =.032). Our data suggest that CD4(+) Treg expansion is a feature of high-risk MDS and progression to aggressive subtypes of the disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available